Nasus Pharma Ltd Capital Expenditures
Nasus Pharma Ltd (NSRX) reported Capital Expenditures of $14.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-25
| Period end | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|
| 2025-12-31 | $14.00K 20-F · filed 2026-03-25 |